Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Ruffolo

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1986
Pharmacological differentiation of pre- and post-junctional alpha 2-adrenoceptorsJ P Hieble, A C Sulpizio, A J Nichols, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 11, 1992
The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonismE H Ohlstein, M Gellai, D P Brooks, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogsD P Brooks, P D dePalma, M Gellai, et al.
Journal of Cardiovascular Pharmacology|April 1, 1995
Cardioprotection and thrombolysis by anistreplase in anesthetized dogsG Z Feuerstein, A J Nichols, R E Valocik, et al.
Journal of Human Hypertension|February 1, 1993
Altered coronary flow reserve in the hypertrophied heart: implications for therapyE O McFalls, D J Duncker, L M Sassen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566R M Edwards, N Aiyar, E H Ohlstein, et al.
European Journal of Pharmacology|August 28, 1998
Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion modelG Feuerstein, G L Liu, T L Yue, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1993
Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injuryE H Ohlstein, S A Douglas, C P Sung, et al.
Pharmacological Reviews|June 1, 1995
International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus updateJ P Hieble, D B Bylund, D E Clarke, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083S A Douglas, P Nambi, M Gellai, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1986
Pharmacological differentiation of pre- and post-junctional alpha 2-adrenoceptorsJ P Hieble, A C Sulpizio, A J Nichols, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 11, 1992
The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonismE H Ohlstein, M Gellai, D P Brooks, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogsD P Brooks, P D dePalma, M Gellai, et al.
Journal of Cardiovascular Pharmacology|April 1, 1995
Cardioprotection and thrombolysis by anistreplase in anesthetized dogsG Z Feuerstein, A J Nichols, R E Valocik, et al.
Journal of Human Hypertension|February 1, 1993
Altered coronary flow reserve in the hypertrophied heart: implications for therapyE O McFalls, D J Duncker, L M Sassen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566R M Edwards, N Aiyar, E H Ohlstein, et al.
European Journal of Pharmacology|August 28, 1998
Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion modelG Feuerstein, G L Liu, T L Yue, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1993
Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injuryE H Ohlstein, S A Douglas, C P Sung, et al.
Pharmacological Reviews|June 1, 1995
International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus updateJ P Hieble, D B Bylund, D E Clarke, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083S A Douglas, P Nambi, M Gellai, et al.
Pageof 23